Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 0 | 0 | 10 | 0 | 1 |
| Gross Profit | 0 | 10 | 10 | 0 | 1 |
| Operating Expenses | 31,150 | 18,430 | 22,280 | 17,910 | 13,040 |
| Operating Income | -31,150 | -18,430 | -22,270 | -17,910 | -13,039 |
| Interest Expense | 0 | 0 | 70 | 0 | 0 |
| Other Income | 2,210 | 0 | 1,960 | 2,460 | 1,139 |
| Pre-tax Income | -28,940 | -18,430 | -20,380 | -15,450 | -11,900 |
| Net Income Continuous | -35,111 | -24,736 | -20,389 | -15,457 | -11,909 |
| Net Income | $-28,940 | $-24,736 | $-20,380 | $-15,450 | $-11,900 |
| EPS Basic Total Ops | -158.46 | -168.07 | -175.27 | -134.45 | -146.46 |
| EPS Basic Continuous Ops | -157.80 | -193.70 | -175.31 | -134.29 | -145.41 |
| EPS Diluted Total Ops | -158.46 | -168.07 | -175.27 | -134.45 | -146.46 |
| EPS Diluted Continuous Ops | -157.80 | -193.70 | -175.31 | -134.29 | -145.41 |
| EBITDA(a) | $-30,930 | $-18,200 | $-22,060 | $-17,730 | $-12,899 |